Alterity Therapeutics Limited (ATHE)
NASDAQ: ATHE · Real-Time Price · USD
3.420
-0.010 (-0.29%)
At close: Dec 5, 2025, 4:00 PM EST
3.390
-0.030 (-0.88%)
After-hours: Dec 5, 2025, 5:44 PM EST
Alterity Therapeutics Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Alterity Therapeutics stock has a target of 12, which predicts a 250.88% increase from the current stock price of 3.42.
Price Target: $12.00 (+250.88%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Jan 30, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Alterity Therapeutics is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Maintains $8 → $12 | Strong Buy | Maintains | $8 → $12 | +250.88% | Jan 30, 2025 |
| Maxim Group | Maxim Group | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +133.92% | Dec 12, 2024 |
| Benchmark | Benchmark | Buy Reiterates $4 | Buy | Reiterates | $4 | +16.96% | Mar 7, 2024 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Maintains $20 → $10 | Strong Buy | Maintains | $20 → $10 | +192.40% | Jun 5, 2023 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $20 | Strong Buy | Initiates | $20 | +484.80% | Aug 3, 2022 |
Financial Forecast
Revenue This Year
4.10M
from 5.44M
Decreased by -24.71%
Revenue Next Year
3.84M
from 4.10M
Decreased by -6.18%
EPS This Year
n/a
from -0.00
EPS Next Year
n/a
Financial currency is AUD. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 8.5M | 8.0M | |||
| Avg | 4.1M | 3.8M | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 56.5% | 95.1% | |||
| Avg | -24.7% | -6.2% | |||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.